Tilray Brands, Inc. (TLRY)

President Trump is reportedly considering an executive order on marijuana reclassification. The order could come as early as Monday.

U.S.-listed cannabis stocks are back in focus as expectations build around a potential shift in federal marijuana policy.

Stock News Tech-led selloff caps tough week: US stocks fell as investors rotated out of mega-cap tech after Broadcom (AVGO) and Oracle (ORCL) stoked AI-spending

Tilray's stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.

The rally marked one of the biggest single-day moves for cannabis stocks in years, snapping a prolonged slump.

Multiple news reports this week said that President Trump is expected to reclassify marijuana's drug scheduling, which would lessen restrictions on its use and potentially allow companies that operate in the cannabis space to increase business.

President Donald Trump is expected have his administration classify marijuana as a less dangerous drug, according to people familiar with the matter. This has been good news for pot stocks.

Trump plans to sign an executive order directing federal agencies to reclassify marijuana from Schedule I to Schedule III. Reclassification could boost after-tax profits by 40% to 70% for U.S. cannabis operators by ending the 280E tax penalty.

Cannabis stocks surged Friday following reports President Donald Trump could soon reclassify marijuana as a less dangerous substance.

Cannabis stocks jumped Friday as the White House moved to significantly ease federal restrictions on marijuana. Brandon Gomez has the latest on the timing of a potential Executive Order and why the industry says it's “more optimistic” this time around.

Tilray shares are trading higher Friday following a report suggesting Trump is expected to reclassify marijuana as a Schedule III drug.

Cannabis stocks haven't moved like this in years, and it took a rare one-two punch to jolt the sector back to life: a Washington Post scoop hinting that President Donald Trump wants to reclassify marijuana into Schedule III — and a Tilray Brands Inc (NASDAQ: TLRY) vape launch so successful it broke the internal math of the company's own product mix.

Tilray Brands Inc (NASDAQ:TLRY) stock is soaring today, after the Washington Post reported that  U.S. President Donald Trump plans to reclassify marijuana and dramatically loosen restrictions.

Reports indicate the President will instruct federal agencies to make marijuana a Schedule III drug soon. This isn't "legalization" per se, but it will make marijuana a bit more "legal.

Live Updates Goldman Sachs Sets a 7,600 Target on S&P 500 for 2026 59 minutes ago As we wrap up 2025, analysts at Goldman Sachs say 2026 could be stronger. In fact, the firm just set a target of 7,600 for the S&P 500, believing that artificial intelligence will be a key catalyst. "The process... Stock Market Live December 12, 2025: S&P 500 (SPY) Slumping with Tech Stocks Tumble.

Live Updates Johnson Outdoors Taken to Woodshed 58 minutes ago Live Camping- and fishing-goods supplier Johnson Outdoors (Nasdaq: JOUT) missed earnings by a massive $2.15 this morning, reporting a fiscal Q4 2025 loss of $2.83 per share. This was despite beating revenue estimates with sales of $135.8 million. Losses did improve year over year (meaning Johnson... Stock Market Live December 12: Trump to Ease Marijuana Regulation, S&P 500 (VOO) Flat.